EdwardB.PerkinsMD

PubMed

• 32 citations
  A Phase II Trial of Bortezomib and Vorinostat in Mantle Cell Lymphoma and Diffuse Large B-cell Lymphoma
  Victor Yazbeck, Danielle Shafer, Edward B. Perkins, Domenico Coppola, Lubomir Sokol, Kristy L. Richards, Thomas B. Shea, Jia Ruan, Samir Parekh, Roger Strair, Christop...> ;Clinical Lymphoma, Myeloma & Leukemia. 2011 Nov 18
• 18 citations
  Phase I Trial of Bortezomib (PS-341; NSC 681239) and “Nonhybrid” (Bolus) Infusion Schedule of Alvocidib (Flavopiridol; NSC 649890) in Patients with Recurrent or Refrac...
  Beata Holkova, Maciej Kmieciak, E. Brent Perkins, Prithviraj Bose, Rachid Baz, G. David Roodman, Robert K. Stuart, Viswanathan Ramakrishnan, Wen Wan, Cody J. Peer, Jan...> ;Clinical Cancer Research. 2014 Nov 15
• 25 citations
  A phase I trial of vorinostat and alvocidib in patients with relapsed, refractory, or poor prognosis acute leukemia, or refractory anemia with excess blasts-2.
  Beata Holkova, Jeffrey G. Supko, Matthew M. Ames, Joel M. Reid, Geoffrey I. Shapiro, Edward B. Perkins, Viswanathan Ramakrishnan, Mary Beth Tombes, Connie Honeycutt, R...> ;Clinical Cancer Research. 2013 Apr 1
• 17 citations
  Phase I Trial of the Combination of Flavopiridol and Imatinib Mesylate in Patients with Bcr-Abl+ Hematological Malignancies
  Prithviraj Bose, Edward B. Perkins, Connie Honeycut, Martha D. Wellons, Tammy Stefan, James W. Jacobberger, Emmanouil Kontopodis, Jan H. Beumer, Merrill J. Egorin, Chi...> ;Cancer Chemotherapy and Pharmacology. 2012 Feb 15
• Join now to see all